M Haaparanta

[18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage.

M Vapalahti, E Mervaala, A. Ylinen, 2001, Archives of neurology.

Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy.

U Ruotsalainen, J Knuuti, P Nuutila, 1999, Circulation.

An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

M Partinen, J O Rinne, J. Rinne, 2000, Neurology.

Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

U Ruotsalainen, M Teräs, J Knuuti, 1992, The Journal of clinical investigation.

Usefulness of a dopamine transporter PET ligand [18F]β-CFT in assessing disability in Parkinson's disease

J O Rinne, J. Rinne, H. Ruottinen, 1999, Journal of neurology, neurosurgery, and psychiatry.

Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer.

U Ruotsalainen, M Teräs, K. Någren, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.

R Härkönen, M Saraste, P Nuutila, 1994, American heart journal.

Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.

P Vicini, U Ruotsalainen, C Cobelli, 1997, The Journal of clinical investigation.

High levels of dopamine activity in the basal ganglia of cigarette smokers.

J. Hietala, M. Haaparanta, O. Solin, 2000, The American journal of psychiatry.

Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.

J O Rinne, J. Rinne, R. Portin, 2000, Archives of neurology.